store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Thioflosulide (L-745337) 是一种具有选择性和高效性的 COX2 抑制剂(IC50:2.3 nM),具有抗炎活性,可用于研究胃溃疡。
产品描述 | Thioflosulide (L-745337) is a selective and potent COX2 inhibitor (IC50: 2.3 nM) with anti-inflammatory activity for the study of gastric ulcers. |
靶点活性 | COX-2:2.3 nM |
体内活性 | In a rat model of postoperative pain, Thioflosulide (L-745337) coadministered intrathecally (40-80 μg) with intrathecal morphine (0.5 nmol) increases withdrawal thresholds in a dose-dependent manner. Adding 80 μg of Thioflosulide (L-745337) to 1 nmol of morphine produces a greater antiallodynic effect than morphine at twice the dose. When combined with intrathecal morphine, Thioflosulide (L-745337) administered subcutaneously (0-30 mg/kg) results in the same antiallodynic response as morphine alone[1].Thioflosulide (L-745337) also exhibits anti-inflammatory activity, with an effective dose of 0.4 mg/kg and a maximal anti-inflammation dose of 5 mg/kg in arthritic rats[3]. |
别名 | L-745337 |
分子量 | 369.41 |
分子式 | C16H13F2NO3S2 |
CAS No. | 158205-05-1 |
store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
Thioflosulide 158205-05-1 Immunology/Inflammation Neuroscience COX L-745337 L 745337 L745337 Inhibitor inhibitor inhibit